These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 17059763)

  • 1. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
    Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB.
    Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L
    Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
    Liao DW; Wang L; Zhang XG; Liu MQ
    Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
    Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z; Ma J; Li N; Sun N; Wang C
    Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
    Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH
    Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
    Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
    Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
    Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
    Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
    Leithner K; Stacher E; Wurm R; Ploner F; Quehenberger F; Wohlkoenig C; Bálint Z; Polachova J; Olschewski A; Samonigg H; Popper HH; Olschewski H
    Lung Cancer; 2009 Jul; 65(1):98-104. PubMed ID: 19081160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
    Min YH; Cheong JW; Kim JY; Eom JI; Lee ST; Hahn JS; Ko YW; Lee MH
    Cancer Res; 2004 Aug; 64(15):5225-31. PubMed ID: 15289327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
    Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
    Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
    Shibahara K; Sugio K; Osaki T; Uchiumi T; Maehara Y; Kohno K; Yasumoto K; Sugimachi K; Kuwano M
    Clin Cancer Res; 2001 Oct; 7(10):3151-5. PubMed ID: 11595709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
    Donati V; Fontanini G; Dell'Omodarme M; Prati MC; Nuti S; Lucchi M; Mussi A; Fabbri M; Basolo F; Croce CM; Aqeilan RI
    Clin Cancer Res; 2007 Feb; 13(3):884-91. PubMed ID: 17289881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
    Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
    Sonobe M; Nakagawa M; Takenaka K; Katakura H; Adachi M; Yanagihara K; Otake Y; Wada H; Tanaka F
    J Surg Oncol; 2007 Jan; 95(1):63-9. PubMed ID: 17192868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.